🇺🇸 FDA
Patent

US 8460864

Methods for identifying compounds that modulate untranslated region-dependent gene expression and methods of using same

granted A61PA61P35/00A61P9/10

Quick answer

US patent 8460864 (Methods for identifying compounds that modulate untranslated region-dependent gene expression and methods of using same) held by PTC THERAPEUTICS, INC. expires Mon Jun 06 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PTC THERAPEUTICS, INC.
Grant date
Tue Jun 11 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 06 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61P, A61P35/00, A61P9/10